Scientifically Grounded Hope for Advanced Cancers
Proven Success with Pancreatic Cancer and Advanced Cancers
We analyze your cancer cells to find the drugs, drug combinations, and sequences that are most effective to treat your cancer.
Samples are sent for analysis from all over the USA or internationally.
By measuring how cancer cells respond to drugs, we can find one or more therapies that kill cancer cells but are least toxic to the patient.
This helps you or your oncologist select the most effective and least toxic treatment for your cancer, even in stage 4 or aggressive cancers.
Proven with decades of peer-reviewed scientific research of more than 10,000 patient studies.
Results in about 7 days.
.png)
Rick Carroll was Referred to Hospice
That’s when his oncologist told him that the treatment wasn’t working and there was nothing left to do. He was told to get his affairs in order and referred him to hospice care.
Luckily, his friends and family didn't give up as easily as his doctor.
Find out how Rick Carroll became one of the longest living survivors of Stage 4 Lung Cancer in the VA system today. He's still alive more than 20 years after diagnosis!
Dr. Nagourney MD is the author of
OUTLIVING CANCER
The Better, Smarter Way to Treat Your Cancer
In this groundbreaking work, Dr. Robert Nagourney reveals how Functional Profiling revolutionizes cancer treatment by testing drugs directly on your living cancer cells.
Discover why one-size-fits-all approaches fail and how personalized treatment selection dramatically improves survival rates. This essential guide offers hope to patients seeking alternatives when standard protocols have failed.
Dr. Robert Nagourney is an internationally recognized pioneer in cancer research and personalized cancer treatment.
With more than 30 years of experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts and abstracts including publications in the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the National Cancer Institute.
Over the past 30+ years, Dr. Nagourney and his team at the Nagourney Cancer Institute have developed a laboratory technique, functional profiling, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.
By using this approach, the Nagourney team can determine the best drugs for each patient before they receive them. This reduces the guesswork in selecting the right drug treatment for you and is why our analysis is more powerful than genomic testing offered by most centers.
Dr. Nagourney Featured on TEDx Talk
Among his many research accomplishments, Dr. Nagourney is recognized for his work in the introduction of Cisplatin/Gemcitabine doublets (two drugs given together) in the treatment of advanced ovarian and breast cancers.
Want to know more about cancer, cancer research and how best to treat cancer?
Click the link below to watch Dr. Nagourney share his unique insight into these topics and explain his treatment philosophy in this engaging TEDx Talk.
You can also click here to see additional videos and TV appearances by Dr. Nagourney on our Cancer Resource Center page.
John Stamos
"He is a tireless man who has really devoted his life to helping people"
Maria Lewis
"You would never know that I was once a cancer patient by looking at me now."
Dr. Robert Nagourney
A Testing Methodology Created by Cancer Research Pioneers
We perform Functional Profiling, a laboratory technique that measures how cancer cells respond when exposed to a variety of drugs and drug combinations.
Functional Profiling is more powerful than genomic testing that most centers offer.
This approach reduces the guesswork from drug selection to find the most effective, least toxic options. Results only take 7 days.
You and your doctor can then use this information to guide your treatment.
CLIA LICENSED LABORATORY
Nagourney Cancer Institute is a CLIA Licensed Laboratory.*
CLIA ID: 05D0871981
California Department of Public Health (CDPH) State ID: CLF-00010526
* Rational Therapeutics DBA Nagourney Cancer Institute